Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 USD | -4.38% | -7.75% | +7.16% |
Financials (USD)
Sales 2024 * | 26.58M | Sales 2025 * | 60.62M | Capitalization | 167M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | -19M | EV / Sales 2024 * | 6.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
-4.45
x | P/E ratio 2025 * |
-8.56
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.74% |
Latest transcript on Capricor Therapeutics, Inc.
1 day | -4.38% | ||
1 week | -7.75% | ||
Current month | -7.75% | ||
1 month | -4.03% | ||
3 months | +3.97% | ||
6 months | +53.22% | ||
Current year | +7.16% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 13-11-19 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 23-07-20 |
Earl Collier
BRD | Director/Board Member | 76 | 13-11-19 |
George Dunbar
BRD | Director/Board Member | 77 | 13-11-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 5.24 | -4.38% | 247,653 |
24-06-06 | 5.48 | -2.49% | 219,147 |
24-06-05 | 5.62 | -3.10% | 391,873 |
24-06-04 | 5.8 | +2.84% | 810,631 |
24-06-03 | 5.64 | -0.70% | 275,588 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.16% | 167M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CAPR Stock